- Home
- BNTX vs ARE Comparison
BNTX vs ARE Comparison
Compare BNTX & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- ARE
- Stock Information
- Founded
- BNTX 2008
- ARE 1994
- Country
- BNTX Germany
- ARE United States
- Employees
- BNTX N/A
- ARE N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- ARE Real Estate Investment Trusts
- Sector
- BNTX Health Care
- ARE Real Estate
- Exchange
- BNTX Nasdaq
- ARE Nasdaq
- Market Cap
- BNTX 26.4B
- ARE 13.2B
- IPO Year
- BNTX 2019
- ARE 1997
- Fundamental
- Price
- BNTX $98.15
- ARE $85.19
- Analyst Decision
- BNTX Strong Buy
- ARE Buy
- Analyst Count
- BNTX 18
- ARE 7
- Target Price
- BNTX $139.49
- ARE $109.57
- AVG Volume (30 Days)
- BNTX 1.2M
- ARE 1.1M
- Earning Date
- BNTX 11-03-2025
- ARE 10-27-2025
- Dividend Yield
- BNTX N/A
- ARE 6.20%
- EPS Growth
- BNTX N/A
- ARE N/A
- EPS
- BNTX N/A
- ARE N/A
- Revenue
- BNTX $3,380,387,551.00
- ARE $3,097,996,000.00
- Revenue This Year
- BNTX N/A
- ARE N/A
- Revenue Next Year
- BNTX $13.50
- ARE N/A
- P/E Ratio
- BNTX N/A
- ARE N/A
- Revenue Growth
- BNTX 6.98
- ARE 3.00
- 52 Week Low
- BNTX $81.20
- ARE $67.37
- 52 Week High
- BNTX $131.49
- ARE $125.60
- Technical
- Relative Strength Index (RSI)
- BNTX 40.46
- ARE 63.93
- Support Level
- BNTX $90.12
- ARE $83.42
- Resistance Level
- BNTX $100.84
- ARE $85.79
- Average True Range (ATR)
- BNTX 3.99
- ARE 1.73
- MACD
- BNTX -0.47
- ARE 0.16
- Stochastic Oscillator
- BNTX 32.42
- ARE 63.73
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.